These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms. Takehara A, Aoyama Y, Kurosawa M, Shirafuji Y, Umemura H, Kamiya K, Ushigome Y, Kano Y, Shiohara T, Iwatsuki K. Br J Dermatol; 2016 Nov; 175(5):944-952. PubMed ID: 27087170 [Abstract] [Full Text] [Related]
7. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS). Miyagawa F, Asada H. Int J Mol Sci; 2021 Feb 21; 22(4):. PubMed ID: 33670052 [Abstract] [Full Text] [Related]
8. Treg depletion attenuates irradiation-induced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFN-γ, IL-12/IL-4, IL-5 balance. Xiong S, Guo R, Yang Z, Xu L, Du L, Li R, Xiao F, Wang Q, Zhu M, Pan X. Immunobiology; 2015 Nov 21; 220(11):1284-91. PubMed ID: 26224246 [Abstract] [Full Text] [Related]
9. Pathological role of regulatory T cells in the initiation and maintenance of eczema herpeticum lesions. Takahashi R, Sato Y, Kurata M, Yamazaki Y, Kimishima M, Shiohara T. J Immunol; 2014 Feb 01; 192(3):969-78. PubMed ID: 24379126 [Abstract] [Full Text] [Related]
11. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. Mitsui Y, Shinkuma S, Nakamura-Nishimura Y, Ommori R, Ogawa K, Miyagawa F, Mori Y, Tohyama M, Asada H. J Allergy Clin Immunol Pract; 2022 Feb 01; 10(2):558-565.e4. PubMed ID: 34757063 [Abstract] [Full Text] [Related]
12. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome. Bohm KJ, Ciralsky JB, Harp JL, Bajaj S, Sippel KC. Cornea; 2016 Jun 01; 35(6):888-91. PubMed ID: 27078005 [Abstract] [Full Text] [Related]
14. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS). Ogawa K, Morito H, Hasegawa A, Daikoku N, Miyagawa F, Okazaki A, Fukumoto T, Kobayashi N, Kasai T, Watanabe H, Sueki H, Iijima M, Tohyama M, Hashimoto K, Asada H. J Dermatol Sci; 2013 Jan 01; 69(1):38-43. PubMed ID: 23141052 [Abstract] [Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations. Teraki Y, Shibuya M, Izaki S. Clin Exp Dermatol; 2010 Oct 01; 35(7):723-8. PubMed ID: 19874350 [Abstract] [Full Text] [Related]
16. The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity. Hanafusa T, Azukizawa H, Matsumura S, Katayama I. J Dermatol Sci; 2012 Mar 01; 65(3):213-9. PubMed ID: 22226608 [Abstract] [Full Text] [Related]
17. Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients. Zhao C, Chu Y, Liang Z, Zhang B, Wang X, Jing X, Hao M, Wang Y, An J, Zhang X, Sun L, Chen J. BMC Immunol; 2019 Sep 04; 20(1):32. PubMed ID: 31484501 [Abstract] [Full Text] [Related]
18. Chemokines in Severe Cutaneous Adverse Reactions (SCARs). Miyagawa F, Asada H. Biomolecules; 2021 Jun 06; 11(6):. PubMed ID: 34204146 [Abstract] [Full Text] [Related]
19. Human CD39+ Treg Cells Express Th17-Associated Surface Markers and Suppress IL-17 via a Stat3-Dependent Mechanism. Magid-Bernstein JR, Rohowsky-Kochan CM. J Interferon Cytokine Res; 2017 Apr 06; 37(4):153-164. PubMed ID: 28387597 [Abstract] [Full Text] [Related]